Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.45
-1.50 (-3.58%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $50 | Buy | Maintains | $50 | +23.61% | Sep 16, 2026 |
| BTIG | BTIG | Buy Reiterates $65 → $75 | Buy | Reiterates | $65 → $75 | +85.41% | Sep 16, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $56 | Buy | Reiterates | $56 | +38.44% | Sep 16, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 20, 2026 |
| Raymond James | Raymond James | Buy Maintains $68 → $75 | Buy | Maintains | $68 → $75 | +85.41% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $66 | Buy | Reiterates | $66 | +63.16% | Aug 17, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $58 → $62 | Buy | Maintains | $58 → $62 | +53.28% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.